Who owns BICARA THERAPEUTICS INC?
- Ticker: BCAX
- CUSIP Number: 055477103
Tip: Access positions for across all investors
Analyze quarterly positions in Bicara Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv

Top investors of Bicara Therapeutics stock
Who bought or sold BICARA THERAPEUTICS INC this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
RA Capital Management | 7.0M | $91M | 0% | Mar 2025 |
|
FMR | 3.6M | $47M | 71% | Mar 2025 |
|
Siren | 3.3M | $43M | 0% | Mar 2025 |
|
Red Tree Management | 3.2M | $41M | 100% | Mar 2025 |
|
Tpg Gp A | 3.0M | $39M | 0% | Mar 2025 |
|
Vestal Point Capital | 2.8M | $36M | 290% | Mar 2025 |
|
Omega Fund Management | 2.2M | $29M | 0% | Mar 2025 |
|
Braidwell | 2.2M | $28M | 8% | Mar 2025 |
|
Deep Track Capital | 2.0M | $26M | 0% | Mar 2025 |
|
Wellington Management Company | 1.4M | $18M | 84% | Mar 2025 |
|
Henderson Group | 1.3M | $18M | 56% | Mar 2025 |
|
BlackRock | 1.3M | $18M | 6% | Mar 2025 |
|
Adage Capital Partners GP | 1.2M | $15M | -46% | Mar 2025 |
|
Vanguard Group | 1.1M | $14M | 0% | Mar 2025 |
|
Blackstone Group | 1.0M | $13M | 13% | Mar 2025 |
|
Fil | 1.0M | $13M | 0% | Mar 2025 |
|
Baker Bros. Advisors | 833k | $11M | 0% | Mar 2025 |
|
Acorn Capital Advisors | 643k | $8.4M | 0% | Mar 2025 |
|
Geode Capital Management | 492k | $6.4M | 5% | Mar 2025 |
|
State Street Corporation | 370k | $4.8M | 21% | Mar 2025 |
|
Schonfeld Strategic Advisors | 366k | $4.8M | 100% | Mar 2025 |
|
Rock Springs Capital Management | 336k | $4.4M | -25% | Mar 2025 |
|
OrbiMed Advisors | 298k | $3.9M | 0% | Mar 2025 |
|
Napean Trading & Investment | 276k | $3.6M | 100% | Mar 2025 |
|
DAFNA Capital Management | 212k | $2.8M | 101% | Mar 2025 |
|
Northern Trust | 154k | $2.0M | -3% | Mar 2025 |
|
Charles Schwab Investment Management | 153k | $2.0M | -2% | Mar 2025 |
|
HealthInvest Partners AB | 147k | $1.4M | 23% | Jun 2025 |
|
TD Asset Management | 131k | $1.7M | 28% | Mar 2025 |
|
Goldman Sachs Group | 126k | $1.6M | -30% | Mar 2025 |
|
Deutsche Bank Aktiengesellschaft | 111k | $1.5M | -1% | Mar 2025 |
|
Manufacturers Life Insurance Company | 69k | $893k | 135% | Mar 2025 |
|
UBS Group | 66k | $858k | -67% | Mar 2025 |
|
Stempoint Capital | 47k | $613k | 100% | Mar 2025 |
|
Bank of New York Mellon | 42k | $550k | 5% | Mar 2025 |
|
Schroder Investment Management Group | 42k | $558k | 100% | Mar 2025 |
|
Skandinaviska Enskilda Banken AB | 38k | $496k | 0% | Mar 2025 |
|
Victory Capital Management | 34k | $449k | 100% | Mar 2025 |
|
Leucadia National Corporation | 31k | $399k | 100% | Mar 2025 |
|
XTX Topco | 29k | $371k | 4% | Mar 2025 |
|
Millennium Management | 26k | $334k | -93% | Mar 2025 |
|
Nuveen | 25k | $326k | 100% | Mar 2025 |
|
Susquehanna International | 25k | $325k | 100% | Mar 2025 |
|
Rhumbline Advisers | 23k | $300k | 21% | Mar 2025 |
|
Jpmorgan Chase & Co | 22k | $284k | -66% | Mar 2025 |
|
Bnp Paribas Arbitrage, Snc | 22k | $280k | 1076% | Mar 2025 |
|
Barclays | 20k | $264k | -33% | Mar 2025 |
|
Wexford Capital | 20k | $261k | 0% | Mar 2025 |
|
AQR Capital Management | 19k | $248k | 100% | Mar 2025 |
|
Citigroup | 18k | $228k | 13% | Mar 2025 |
|
Intech Investment Management | 17k | $218k | 100% | Mar 2025 |
|
Invesco | 15k | $194k | -3% | Mar 2025 |
|
Franklin Resources | 14k | $178k | 100% | Mar 2025 |
|
Two Sigma Investments | 13k | $166k | 100% | Mar 2025 |
|
MetLife Investment Advisors | 12k | $159k | 0% | Mar 2025 |
|
Federated Investors | 12k | $156k | 50% | Mar 2025 |
|
Mirae Asset Global Etfs Holdings | 11k | $148k | 4% | Mar 2025 |
|
Caxton | 11k | $143k | 0% | Mar 2025 |
|
Wells Fargo & Company | 10k | $134k | 2% | Mar 2025 |
|
Corebridge Financial | 9.5k | $123k | -1% | Mar 2025 |
|
Virtus Investment Advisers | 9.1k | $119k | 100% | Mar 2025 |
|
Avanza Fonder AB | 6.6k | $61k | -1% | Jun 2025 |
|
New York State Common Retirement Fund | 4.0k | $52k | 100% | Mar 2025 |
|
CWM | 2.2k | $29k | 100% | Mar 2025 |
|
Summit Investment Advisors | 2.0k | $26k | 0% | Mar 2025 |
|
Legal & General Group | 1.9k | $25k | 0% | Mar 2025 |
|
California State Teachers Retirement System | 1.4k | $19k | 0% | Mar 2025 |
|
Larson Financial Group | 1.1k | $14k | 100% | Mar 2025 |
|
Tower Research Capital | 922.00 | $12k | -13% | Mar 2025 |
|
Royal Bank of Canada | 865.00 | $11k | -43% | Mar 2025 |
|
GAMMA Investing | 677.00 | $6.3k | 14% | Jun 2025 |
|
Amalgamated Bank | 658.00 | $9.0k | 0% | Mar 2025 |
|
Us Bancorp | 567.00 | $7.4k | 100% | Mar 2025 |
|
Hanson McClain Advisors | 325.00 | $5.1k | 100% | Mar 2025 |
|
13F Holdings Report | 200.00 | $2.6k | 0% | Mar 2025 |
|
NISA Investment Advisors | 163.00 | $2.1k | 100% | Mar 2025 |
|
Sterling Capital Management | 162.00 | $2.1k | -41% | Mar 2025 |
|
Simplex Trading | 154.00 | $2.0k | 100% | Mar 2025 |
|
EverSource Wealth Advisors | 102.00 | $1.3k | 100% | Mar 2025 |
|
Versant Capital Management | 95.00 | $882.996500 | 100% | Jun 2025 |
|
Lindbrook Capital | 71.00 | $925.002200 | 100% | Mar 2025 |
|
True Wealth Design | 33.00 | $429.999900 | 100% | Mar 2025 |
|
Rothschild Investment | 20.00 | $261.000000 | 100% | Mar 2025 |
|
Who sold out of Bicara Therapeutics?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Deerfield Management Company | Dec 2024 | 1.8M | $31M |
Alliancebernstein | Dec 2024 | 821k | $14M |
First Turn Management | Dec 2024 | 346k | $6.0M |
Boxer Capital Management | Dec 2024 | 135k | $2.4M |
Norges Bank Investment Management | Dec 2024 | 70k | $1.2M |
Marshall Wace | Dec 2024 | 68k | $1.2M |
Maven Securities | Dec 2024 | 25k | $436k |
Verition Fund Management | Dec 2024 | 22k | $377k |
LMR Partners | Dec 2024 | 15k | $264k |
SG Americas Securities | Dec 2024 | 8.4k | $147k |
Virtus ETF Advisers | Dec 2024 | 3.9k | $69k |
OTR - Nominee Name for The State Teachers Retirement Board of Ohio | Dec 2024 | 3.6k | $63k |
Spire Wealth Management | Dec 2024 | 1.8k | $31k |
Advisor Group Holdings | Dec 2024 | 255.00 | $4.4k |
Signature | Mar 2025 | 80.00 | $1.0k |
MRP Capital Investments | Dec 2024 | 20.00 | $349.000000 |